EP 1120B - Prompt Recognition & Treatment Found Effective for Lung Disease Patients Who Receive New Drug

Guest Bio: Dr. Charles Powell, MD, MBA

Dr. Charles A. Powell is Professor of Medicine and System Division Chief for Pulmonary, Critical Care and Sleep Medicine at the Icahn School of Medicine at Mount Sinai in New York and Medical Director of Respiratory Therapy at Mount Sinai Hospital.  He received his medical degree at University of Chicago and trained in Internal Medicine at Columbia University and in Pulmonary and Critical Care Medicine at Boston University.  A primary focus of Dr. Powell’s research and clinical activities is lung cancer.  He also directs research programs focused on early detection of lung interstitial disease and airways disease.  Dr. Powell is NIH funded,  has published over 100 articles, and directs a NIH funded laboratory that examines the genomics of lung cancer and lung fibrosis.  He was the founding chair of the ATS Assembly on Thoracic Oncology and he sees patients in consultation regarding lung nodules and lung cancer.  Dr. Powell’s International Reputation in the field is demonstrated by his election as President of the Fleischner Society.  Dr. Powell is the CEO of the Mount Sinai-National Jewish Health Respiratory Institute that is a partnership of The Icahn School of Medicine at Mount Sinai, a top ranked academic medical center in New York City, and National Jewish Health, the nation’s leading respiratory hospital based in Denver, Colorado. Combining the strengths of both entities into an integrated Respiratory Institute brings together leading expertise in diagnosing and treating all forms of respiratory illness and lung disease, including asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD) and bronchiectasis. Through the integration of research advances, clinical skill and patient-focused processes and protocols, the Respiratory Institute offers a model for the state-of-the- art delivery of multidisciplinary, outcomes-driven care, and for the application of precision medicine for the treatment of respiratory disease.